HSDTライブシグナル | Getagraph.comで利益を最大化

買う 147473 min ago

@ $6.10

発行日: 9 2月 2024 @ 04:18

リターン: -77.55%

Live Chart Being Loaded With Signals

Commentary (21 5月 2024 @ 05:00):

Stats
本日の出来高	669 419
平均出来高	544 916
時価総額	3.47M
EPS	$0 ( 2024-05-13 )
次の収益日	( $-1.270 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00900 (0.66%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-01	Andreeff Dane	Buy	643	Common Stock
2023-11-30	Andreeff Dane	Buy	641	Common Stock
2023-12-14	Andreeff Dane	Buy	2 827	Common Stock
2023-12-14	Andreeff Dane	Buy	1 603	Common Stock
2023-12-14	Andreeff Dane	Buy	570	Common Stock

INSIDER POWER
100.00
Last 99 transactions
Buy: 12 106 108 \| Sell: 0

ボリューム相関

長: -0.19 (neutral)

短: -0.44 (neutral)

Signal:(38.698) Neutral

Helius Medical 相関

10 最も正の相関
CETX	0.937
CZR	0.927
VRSN	0.924
INTC	0.917
AEMD	0.908
III	0.906
VAXX	0.903
XRAY	0.9
UTRS	0.897
AUGX	0.895

10 最も負の相関
NTIC	-0.937
CGEM	-0.926
SGMA	-0.92
PRCT	-0.917
BOCN	-0.908
IGTA	-0.907
XFIN	-0.903
PI	-0.9
TUR	-0.896
VCTR	-0.896

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Helius Medical 相関 - 通貨/商品

0.52
( weak )

-0.25
( neutral )

0.00
( neutral )

-0.39
( neutral )

0.08
( neutral )

Helius Medical 財務諸表

Annual	2023
収益:	$644 000
総利益:	$-101 000 (-15.68 %)
EPS:	$-14.56

FY	2023
収益:	$644 000
総利益:	$-101 000 (-15.68 %)
EPS:	$-14.56

FY	2022
収益:	$787 000
総利益:	$324 000 (41.17 %)
EPS:	$-46.52

FY	2021
収益:	$522 000
総利益:	$224 000 (42.91 %)
EPS:	$-0.433

Financial Reports:

No articles found.

Helius Medical Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Helius Medical

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.